Oct 13, 2019 by Motley Fool StaffPayPal Backs Away From LibraPayPal is the first of the 28 companies involved with the cryptocurrency project to step away.
Oct 13, 2019 by Motley Fool StaffAn Introduction to Real Estate CrowdfundingHere’s a primer on this new and exciting way to invest in real estate.
Oct 13, 2019 by Motley Fool StaffZero-Commission Trading: What Investors Should KnowIn the past week, four major brokers got rid of stock trading commissions.
Oct 13, 2019 by Matt DiLalloSailing the Waters of Midstream InvestingOur analysts look at three solid midstream picks with low risks and high dividend potential.
Oct 13, 2019 by Todd Campbell3 Beaten-Up Biotechs -- Are They Buys?Is it finally time to add these three fallen biotech stocks to your portfolio?
Oct 10, 2019 by Daniel B. Kline2 New Fashion IPOsMadewell and Old Navy are spinning out of their parents, but investors should tread carefully on these threads.
Oct 10, 2019 by Joey SolitroThe X's and O's of IPOsOur analysts explain the IPO process, from deciding to go public to being traded on the exchanges.
Oct 8, 2019 by Matt Frankel, CFPZero-Commission Stock Trading, Crowdfunded Real Estate Investing, and MoreThis sure is an exciting time to be an investor.
Oct 8, 2019 by Motley Fool StaffMichaels Is Worth Putting on Your Watch List as a Potential Value PurchaseMaybe it doesn’t make sense to buy Michaels today, but value-conscious investors should keep an eye on the retailer in 2020.
Oct 8, 2019 by Motley Fool StaffBuying Michaels as a Value Play? Consider These RisksWe delve further into the question of whether Michaels is a value stock -- or value trap.
Oct 8, 2019 by Motley Fool StaffWill Recent Business Changes Turn Michaels Around?An interim CEO institutes tactical and strategic initiatives to try to jump-start lagging sales.
Oct 8, 2019 by Motley Fool StaffMichaels: The Lure and Risks of a Publicly Traded Crafts ChainAn overview of the sprawling retail enterprise.
Oct 7, 2019 by Daniel B. KlineThe Future of Last-Mile LogisticsGetting goods to customers is a race to the bottom for companies, but it’s pushing innovation in a big way.
Oct 4, 2019 by Todd Campbell and Shannon JonesHow Amazon Is Shaking Up Telemedicine, Plus 1 Winner and 1 Loser Exiting ESMOSeattle Genetics and Amgen are the stocks to watch following this year's European Society for Medical Oncology meeting.
Oct 2, 2019 by Motley Fool StaffMichaels: Value Play or Value Trap?Michaels could offer patient shareholders some serious value, but not without a fair share of risk.
Oct 1, 2019 by Daniel B. KlineWhat’s Up With All These Rewards Cards?Everyone and their dog wants you to sign up for their rewards card. What does it mean for consumers?
Oct 1, 2019 by Benjamin RaChecking In on ChinaNot every Chinese tech stock is like Amazon in the early '00s, but there's still plenty of potential for investors.
Sep 30, 2019 by Motley Fool StaffHere's How HealthEquity Lowers Healthcare CostsThe nation's leading provider of health savings accounts helps employers and employees alike save big on their healthcare expenses.
Sep 29, 2019 by Jason HallThe Legacy of T. Boone PickensOil baron, wildcatter, hostile takeovers, clean energy champion -- T. Boone had a huge impact on the world.
Sep 27, 2019 by Motley Fool StaffHow Telemedicine Can Significantly Lower the Cost of CareLooking for ways to save money on healthcare? Here's why telemedicine might be a big part of the answer.
